CDC Pandemic Influenza Laboratory Network

CDC Pandemic Influenza Laboratory Network
Name	CDC Pandemic Influenza Laboratory Network
Abbreviation	PFLN
Formation	2005
Type	Laboratory network
Headquarters	Atlanta, Georgia
Parent organization	Centers for Disease Control and Prevention
Region served	United States, global partners

CDC Pandemic Influenza Laboratory Network

The CDC Pandemic Influenza Laboratory Network serves as a coordinated laboratory system linking the Centers for Disease Control and Prevention with state, local, territorial, and international laboratories to detect, characterize, and monitor influenza viruses with pandemic potential. The network integrates surveillance, virology, biosafety, and data-sharing functions to support public health actions, clinical guidance, and vaccine strain selection.

Overview

The network operates at the intersection of federal public health infrastructure and laboratory science, aligning Centers for Disease Control and Prevention laboratory leadership with state health laboratory programs, World Health Organization Collaborating Centers, and agencies such as the Food and Drug Administration, National Institutes of Health, and Department of Health and Human Services. It supports interactions with international partners including World Health Organization, Pan American Health Organization, European Centre for Disease Prevention and Control, and national public health institutes like the Public Health Agency of Canada and the Robert Koch Institute. Routine activities tie into surveillance systems run by National Respiratory and Enteric Virus Surveillance System, vaccine strain selection processes involving Global Influenza Surveillance and Response System, and regulatory review pathways administered by Biologics Control Laboratory counterparts.

History and Development

The network grew from influenza laboratory collaborations that intensified after notable events such as the 1918 influenza pandemic, the emergence of 2009 H1N1 pandemic, and concerns following outbreaks like H5N1 avian influenza incidents. Post-2005 investments aligned with preparedness initiatives championed by administrations and legislative actions involving Pandemic and All-Hazards Preparedness Act and interagency planning led by Office of the Assistant Secretary for Preparedness and Response. Partnerships expanded through cooperative agreements with state public health laboratories, technical guidance from Institute of Medicine reports, and laboratory capacity-building supported by international programs from USAID and Centers for Disease Control and Prevention global health divisions.

Structure and Membership

Membership encompasses a tiered configuration linking CDC headquarters laboratories in Atlanta, Georgia with state public health laboratories in jurisdictions such as California Department of Public Health, New York State Department of Health, and Texas Department of State Health Services, as well as territory and tribal laboratories. The network includes designated reference laboratories, sentinel clinical laboratories, and collaborating laboratories at institutions like the Broad Institute, university medical centers (for example Johns Hopkins Hospital, Mayo Clinic), and military research entities such as Walter Reed Army Institute of Research. International nodes include National Institute for Viral Disease Control and Prevention (China), National Centre for Infectious Diseases (Singapore), and other national influenza centers recognized by the World Health Organization.

Roles and Responsibilities

Core responsibilities include detection of novel influenza strains, antigenic and genetic characterization, antiviral resistance monitoring, and sharing virus isolates for vaccine development with World Health Organization Collaborating Centre for Reference and Research on Influenza (UK), World Health Organization Collaborating Centre for Reference and Research on Influenza (USA), and vaccine manufacturers like Sanofi, GSK, and Seqirus. The network provides laboratory confirmation for clinical cases reported under surveillance systems such as FluView and supports public health decision-making by informing entities like Advisory Committee on Immunization Practices and regulatory reviewers at the Food and Drug Administration. Laboratories maintain biosafety and biosecurity standards guided by frameworks from Occupational Safety and Health Administration and National Institutes of Health biosafety manuals.

Laboratory Methods and Capabilities

Participating laboratories employ molecular diagnostics including reverse transcription polymerase chain reaction assays standardized with controls from Diagnostic Standards and Controls programs, next-generation sequencing platforms from vendors such as Illumina and Oxford Nanopore Technologies, viral culture in certified biosafety level facilities, antigenic characterization by hemagglutination inhibition and microneutralization assays, and antiviral phenotypic testing. Bioinformatics pipelines link sequence data to repositories like GenBank and surveillance databases coordinated with Global Initiative on Sharing All Influenza Data. Quality assurance and proficiency testing reference programs involve collaborations with College of American Pathologists and national reference labs.

Coordination with Public Health Partners

The network coordinates laboratory surveillance with epidemiologic partners including State Health Departments, Indian Health Service, Association of Public Health Laboratories, and international partners via World Health Organization mechanisms. During outbreaks, laboratory data are rapidly communicated to incident management systems such as National Incident Management System and agencies like Federal Emergency Management Agency to inform resource allocation and public messaging by entities including Health and Human Services leadership. Collaboration with academic centers like Centers for Vaccine Research (University of Pittsburgh) and industry partners supports translational activities from detection to vaccine and therapeutic evaluation.

Preparedness, Response, and Exercises

Preparedness activities include proficiency exercises, tabletop simulations with stakeholders such as Governor's offices, deployment drills coordinated with Strategic National Stockpile logistics, and surge-capacity planning with clinical laboratory networks like Clinical Laboratory Improvement Amendments-certified laboratories. The network participates in interagency exercises modeled after historical responses to events like the 2009 H1N1 pandemic and evaluates readiness through performance metrics used by Congressional Homeland Security Committees and federal oversight bodies. Continuous improvement cycles incorporate after-action reports, recommendations from panels such as the National Academies of Sciences, Engineering, and Medicine, and investments driven by national preparedness priorities.

Category:Centers for Disease Control and Prevention